104 related articles for article (PubMed ID: 1841819)
1. Correction of fasting hyperglycaemia with insulin or sulphonylurea lowers fasting ketone levels, but does not alter resting or post-glucose energy expenditure in non insulin dependent diabetes. Differences between the OGTT and the glucose clamp.
Boyd K; Boreham C; Andrews WJ; Hadden DR
Diabetes Res; 1991 Nov; 18(3):101-8. PubMed ID: 1841819
[TBL] [Abstract][Full Text] [Related]
2. Three months energy restricted diet does not reduce peripheral insulin resistance in newly diagnosed non insulin dependent diabetics.
Walshe K; Andrews WJ; Sheridan B; Woods R; Hadden DR
Horm Metab Res; 1987 May; 19(5):197-200. PubMed ID: 3556373
[TBL] [Abstract][Full Text] [Related]
3. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
[TBL] [Abstract][Full Text] [Related]
4. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
[TBL] [Abstract][Full Text] [Related]
5. Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals.
DeFronzo RA; Simonson DC
Diabetes Care; 1984; 7 Suppl 1():72-80. PubMed ID: 6428844
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus.
Rajamand N; Ungerstedt U; Brismar K
Diabetes Obes Metab; 2005 Sep; 7(5):525-35. PubMed ID: 16050945
[TBL] [Abstract][Full Text] [Related]
7. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro characterization of insulin resistance in three cases of lipoatrophic diabetes.
Robert JJ; Magre J; Reynet C; Darmaun D; Picard J; Capeau J
Diabete Metab; 1990; 16(3):240-7. PubMed ID: 2210020
[TBL] [Abstract][Full Text] [Related]
9. Effect of a sulfonylurea and insulin on energy expenditure in type II diabetes mellitus.
Welle S; Nair KS; Lockwood D
J Clin Endocrinol Metab; 1988 Mar; 66(3):593-7. PubMed ID: 3127418
[TBL] [Abstract][Full Text] [Related]
10. Glucose flux in controlled hyperglycaemia before and after oral glucose ingestion in men with mild type 2 diabetes.
Rigalleau V; Beauvieux MC; Gallis JL; Gin H; Schneiter P; Tappy L
Diabetes Metab; 2010 Jun; 36(3):234-9. PubMed ID: 20303815
[TBL] [Abstract][Full Text] [Related]
11. Effects of diet composition and ketosis on glycemia during very-low-energy-diet therapy in obese patients with non-insulin-dependent diabetes mellitus.
Gumbiner B; Wendel JA; McDermott MP
Am J Clin Nutr; 1996 Jan; 63(1):110-5. PubMed ID: 8604657
[TBL] [Abstract][Full Text] [Related]
12. Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus.
Groop L; Widén E; Franssila-Kallunki A; Ekstrand A; Saloranta C; Schalin C; Eriksson J
Diabetologia; 1989 Aug; 32(8):599-605. PubMed ID: 2506091
[TBL] [Abstract][Full Text] [Related]
13. Glucose effectiveness and insulin sensitivity measurements derived from the non-insulin-assisted minimal model and the clamp techniques are concordant.
Henriksen JE; Alford F; Ward G; Thye-Rønn P; Levin K; Hother-Nielsen O; Rantzau C; Boston R; Beck-Nielsen H
Diabetes Metab Res Rev; 2010 Oct; 26(7):569-78. PubMed ID: 20830736
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of improvement in glucose metabolism after chronic glyburide therapy.
Simonson DC; Ferrannini E; Bevilacqua S; Smith D; Barrett E; Carlson R; DeFronzo RA
Diabetes; 1984 Sep; 33(9):838-45. PubMed ID: 6432610
[TBL] [Abstract][Full Text] [Related]
15. Partial recovery of insulin secretion and action after combined insulin-sulfonylurea treatment in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral agents.
Del Prato S; Vigili de Kreutzenberg S; Riccio A; Maifreni L; Duner E; Lisato G; Iavicoli M; Tiengo A
Diabetologia; 1990 Nov; 33(11):688-95. PubMed ID: 2127573
[TBL] [Abstract][Full Text] [Related]
16. Insulin, glibenclamide or metformin treatment for non insulin dependent diabetes: heterogenous responses of standard measures of insulin action and insulin secretion before and after differing hypoglycaemic therapy.
Boyd K; Rogers C; Boreham C; Andrews WJ; Hadden DR
Diabetes Res; 1992 Feb; 19(2):69-76. PubMed ID: 1286541
[TBL] [Abstract][Full Text] [Related]
17. The differential effect of insulin in vivo on the peripheral utilization of glucose and ketone bodies in the rat.
Herndon CM; Schade DS; Eaton RP
Horm Metab Res; 1979 Apr; 11(4):270-5. PubMed ID: 110659
[TBL] [Abstract][Full Text] [Related]
18. Effects of ketone bodies on carbohydrate metabolism in non-insulin-dependent (type II) diabetes mellitus.
Henry RR; Brechtel G; Lim KH
Metabolism; 1990 Aug; 39(8):853-8. PubMed ID: 1974025
[TBL] [Abstract][Full Text] [Related]
19. Thermic and metabolic responses to oral glucose in obese subjects with non-insulin-dependent diabetes mellitus treated with insulin or a very-low-energy diet.
Gougeon R
Am J Clin Nutr; 1996 Jul; 64(1):78-86. PubMed ID: 8669419
[TBL] [Abstract][Full Text] [Related]
20. Effect of sulphonylurea therapy on plasma insulin, intact and 32/33 split proinsulin in subjects with type 2 diabetes mellitus.
Davies MJ; Metcalfe J; Day JL; Grenfell A; Hales CN; Gray IP
Diabet Med; 1994 Apr; 11(3):293-8. PubMed ID: 8033529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
